Cita APA (7a ed.)
Sura, S., Bupathi, M., Morris, V., Conkling, P., Todoroff, K., Bhanegaonkar, A., & Ike, C. (2025). Real-World Clinical Outcomes with First-Line Systemic Treatment and Avelumab Maintenance in US Patients with Locally Advanced or Metastatic Urothelial Carcinoma: The SPEAR Bladder-II Study. Current Oncology, 32(4), 187-201.
Cita Chicago Style (17a ed.)
Sura, Sneha, Manojkumar Bupathi, Valerie Morris, Paul Conkling, Karen Todoroff, Abhijeet Bhanegaonkar, y Chiemeka Ike. "Real-World Clinical Outcomes with First-Line Systemic Treatment and Avelumab Maintenance in US Patients with Locally Advanced or Metastatic Urothelial Carcinoma: The SPEAR Bladder-II Study." Current Oncology 32, no. 4 (2025): 187-201.
Cita MLA (9a ed.)
Sura, Sneha, et al. "Real-World Clinical Outcomes with First-Line Systemic Treatment and Avelumab Maintenance in US Patients with Locally Advanced or Metastatic Urothelial Carcinoma: The SPEAR Bladder-II Study." Current Oncology, vol. 32, no. 4, 2025, pp. 187-201.
Precaución: Estas citas no son 100% exactas.